![Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease | Arteriosclerosis, Thrombosis, and Vascular Biology Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/937456a3-0850-464c-a3f3-d4046600cba7/atvbaha.120.314050.fig06.jpg)
Novel Insights From Human Studies on the Role of High-Density Lipoprotein in Mortality and Noncardiovascular Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
![CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels | Scientific Reports CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-47456-2/MediaObjects/41598_2019_47456_Fig1_HTML.png)
CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels | Scientific Reports
![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/asset/e7bea1cf-fd0f-4862-a6ab-fcbb2ff7e6b6/gr1.jpg)